Pharma Journalist

Skin Microbiome & Cosmeceutical Congress: USA
2019-10-29 - 2019-10-30 | Paradise Point Resort & Spa, San Diego, USA, United States
This conference is dedicated to exploring the burgeoning field of skin microbiome research, with case studies focusing on topics such atopic dermatitis, psoriasis, acne, and allergy, and the microbiome-based products being developed to fight these diseases. The conference will also provide insight into the future of microbiome-based cosmetics, with numerous presentations on trial design, commercial strategy, and consumer awareness and expectations.

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress
2019-10-24 - 2019-10-25 | Boston, USA
MarketsandMarkets is proud to announce the 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on 24th-25th October 2019 in Boston, USA. With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities.
Real-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural, the 2nd Annual Real-World Data and Life Science Analytics Congress will hold discussions on accelerating the adoption of Real-world evidence within the industry while understanding the capabilities of newer technologies for evidence generation. The congress will also address upcoming changes in the regulatory landscape with the recent framework by the FDA.
Our aim for the 2nd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.

BioNetwork 2019
2019-10-23 - 2019-10-25 | The Ritz-Carlton Laguna Niguel, CA
BioNetwork
October 23 – 25, 2019
The Ritz-Carlton Laguna Niguel, CA
For the past 15 years, BioNetwork has brought together the most senior-level decision makers in pharma and biotech deal-making (CEOs of BioTechs, VPs of BD from Big Pharma). Meet the right people and create the ideal partnerships.

Discount Code: BN19PJ
To learn more about BioNetwork 2019 and to register online, visit http://bit.ly/2ZnZSRN

Neuromuscular Drug Development Summit (NMD)
2019-10-23 - 2019-10-25 | The Westin Boston Waterfront, 425 Summer Street, Boston, Massachusetts, 02210, United States
Now in its 2nd year, the industry-focused NMD Summit will overcome the challenges preventing neuromuscular drug developers bringing truly transformative therapeutics to market.
With an emphasis on ALS, SMA, DMD and other rare diseases, 18 expert speakers from the likes of Biogen, Audentes and PTC Therapeutics will share their insights across 3 packed days.
Join 90+ neuromuscular stakeholders at this definitive forum to exchange novel ideas, gather lessons learned and establish new collaborations.
To learn more about this event, and to register online, visit https://ter.li/bgvvh7

3rd Annual NASH Summit Europe 2019
2019-10-23 - 2019-10-25 | The Waldorf Hilton, London, Aldwych, London, WC2B 4DD, United Kingdom
Welcome to Europe’s Gathering of NASH Drug Developers: The 3rd NASH Summit Europe

Deepen Understanding of the Role of Liver Fibrosis in NASH
Confidently Meet Regulatory Guidelines
Define Clinical Trial Endpoints

Returning as the only NASH forum exclusively facilitating industry-to-industry dialogue and collaboration in Europe; the 3rd NASH Summit Europe will once again showcase leading data and leverage expert insights to advance pipeline success in NASH.
“The NASH Summit was unlike any scientific meeting I have ever been to. Everyone who attended was interested in some aspect of drug development for NASH. I truly enjoyed the “applied science” focus of the meeting as it helped me where I most needed the help. The opportunity to network and learn informally in the poster session and during receptions was excellent.”
Eli Lilly
See & hear from the 3rd NASH Summit Boston attendees to better understand how the NASH Summit is uniquely dedicated to advancing the therapeutic potential of NASH therapeutic
To learn more about this event, and to register online, visit https://nash-europe.com/
Contact:
Phone – +44 (0)20 3141 8700
Email – info@hansonwade.com

Lyophilization USA
2019-10-23 - 2019-10-24 | Sheraton Boston Hotel, 39 Dalton Street, Boston, MA, 02199, United States
SMi Presents the 5th annual
Lyophilization USA Conference
Date: October 23-24, 2019
Workshop: October 25, 2019
Location: Sheraton Boston Hotel, 39 Dalton Street, Boston, MA, USA
Website: www.lyophilisation-usa.com/PJBan
About Lyophilization USA
The SMi Group is pleased to invite you to the 5th Annual Lyophilization USA Conference arranged to take place on the 23rd and 24th October 2019, in Boston.

The current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution. This instability or degradation can result in suboptimal product performance and even toxicity in worst cases indicating the need for lyophilization despite it’s inherently expensive running costs and time-consuming process.
Join us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of lyophilization. Benchmark and network with industry leaders and discuss the most up to date and relevant topics that delve into alternative lyophilization approaches, applied statistical modelling, fresh views on scaling up and tech transfer, pre- and post-product characterization. regulation and beyond.
DISCUSSION HIGHLIGHTS:
Gain valuable insight into the most current challenges and considerations when working with highly concentrated and sensitive formulations
Explore new and innovative approaches in model-based studies that utilise the power of statistical analysis to improve process development and understanding
Discuss the future outlook of lyophilization through trends in alternative approaches
Discover updates on the leading PAT technologies such as controlled nucleation, continuous freeze drying, low-frequency Raman, vacuum-foam drying and more.
Listen to key opinion leaders and experts from regulatory bodies speak about expectations and the assessment of reliable technologies in the market
View the full agenda: www.lyophilisation-usa.com/PJBan
Contact Info:
T: +44 (0) 20 7827 6164
E: nhoward@smi-online.co.uk

SAPHEX 2019
2019-10-23 - 2019-10-24 | GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, South Africa
SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.

SAPHEX serves a primary platform for both local and international companies working in the South African or Africa pharmaceutical manufacturing industry. The exhibition brings together key visiting pharma suppliers and buyers, with a range of exhibitors from across the pharmaceutical sector.
Don’t miss out on your chance to participate at this event.
To learn more about this event and to register online, visit www.saphex.co.za

2nd Targeted Protein Degradation Summit
2019-10-22 - 2019-10-24 | Hilton Boston Logan Airport, One Hotel Drive, Boston, MA, 02128, United States
Finally Drug the “Undruggable” Through Targeted Protein Degradation. Encapsulating the excitement of the field of protein degradation; The 2nd TPD Summit 2019 is the definitive, comprehensive and industry-dedicated conference for the field of protein degradation – focused on optimizing target validation, improving medicinal chemistry & rational design and ultimately accelerating the translation of selective, bioavailable and effective protein degraders into clinical trials.
With 50+ speakers, 40+ late-breaking case studies, 3 dedicated streams, 6 technical deep-dives & 400+ attendees, TPD 2019 is the most comprehensive and the definitive guide for large pharma, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.
As the previously untapped drug discovery opportunity promised within the proteome becomes a reality and “undruggable” targets are finally being reached, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results, it’s clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential.
View the program and speaker list here: https://ter.li/idctdn

Lab Asset & Facility Management In Pharma 2019
2019-10-22 - 2019-10-24 | The Westin San Diego, 400 West Broadway, San Diego, CA, 92101, United States
The 2nd annual Lab Asset & Facility Management in Pharma summit is the only industry-led platform to join 120+ senior experts from Lab Operations, Facility Management, Lab Supplies and Procurement across pharma, biotech, CROs and research institutions.

Join your colleagues who are beginning to implement end-to-end asset management programs to optimize spend and gain better visibility of inventory and equipment lifecycles in order to maximize capital efficiency.
At the event, you’ll delve into your core challenges, including:

How to increase R&D productivity and avoid unnecessary downtime
Revise the operating model for lab facility and asset supplies
Optimize utilization of lab equipment and facility footprint
Explore new technologies and IoT for asset monitoring and predictive maintenance
Extend and manage your equipment lifecycle
Evaluate your relationships and collaborations with OEMs

Don’t miss out on this one of a kind meeting to engage with your peers and re-define best practice for tomorrow’s operations!
To learn more and to register online, visit: https://ter.li/lafm-listing-home

Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference
2019-10-21 - 2019-10-22 | Sheraton Boston Hotel, Boston USA, United States
SMi is delighted to announce its USA Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21th – 22th October 2019.
The inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? These questions will be answered along with unique insights including HPAPI manufacturing technologies.
Attend the conference and join our networking platform with industry professionals to provide you with the expertise to overcome challenges.
DISCUSSION HIGHLIGHTS:
Oncology Antibody-Drug Conjugates (ADC), the ongoing developments and the containment challenges imposed
How to correctly assess, plan and implement the most cost-effective containment
Emerging HPAPI therapies, oncolytic viruses their potential and challenges
Alternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing
The reality of oncology ADC and HPAPI: are most drugs using ‘highly-potent’ to improve brand image? Has 50 years of ADC R&D for oncology with no cure shows signs of no promise?
View the full agenda: www.hpapi-usa.com/PJwl

LogiMed 2019
2019-10-16 - 2019-10-17 | ROTTERDAM – NHOW HOTEL
LogiMed is the only European event designed for medical device supply chain directors and their teams. It is where Heads of Supply Chain and Logistics from the top pharma companies in Europe gather to benchmark, interact, network and develop professionally.
Only at LogiMed will you have the chance to learn from and network with all the major medical device companies, key hospitals, and the most innovative industry suppliers. All openly sharing the do’s and don’ts to help you adapt to new regulations, redefine your supply chain strategy-covering planning, logistics and customer service to achieve greater end-to-end supply chain operations.
Download the agenda to find out exactly who is speaking, what the hottest topics are and how LogiMed can benefit you. LogiMed 2019 will bring together 250 Medical Device Supply Chain Professionals and 50 expert speakers over 2 value packed days.
Mixing interactive presentations from Global Heads of Supply Chain with practical, interactive ‘how to’ case studies from proven procurement experts; LogiMed helps Medical Device Manufacturers to transform their supply chain.
As a proud Media partner of the event, we are pleased to offer you an exclusive 15% discount off the full price to attend, using our code: PHARMAJOUR19
Book your place online here: https://bit.ly/2J5viSu

Marketing and Customer Innovation Europe
2019-10-15 - 2019-10-16 | Novotel West London One Shortlands, London, W6 8DR, United Kingdom
We’re at a crossroads. On the one hand, pharma marketeers must adopt and master an array of technological innovations to transform customer relationships and better meet rising expectations.
On the other, successful innovation is currently inhibited by our failure to master the basics – with inconsistent multichannel interaction and a low cultural acceptance of non-traditional methods, whether it’s digital or education-led initiatives.
Let’s build the capability to create new collaborations and partnerships, both internally and externally, to strengthen what’s possible yet at the same time deliver on the fundamentals of customer-value. It’s no longer a nice-to-have – we must do this or face rapid extinction.
eyeforpharma Marketing and Customer Innovation Europe will bring together 250+ Marketing, Digital, CX, IT/CRM and Business Partnership/Technology pharma executives to bridge internal divides, share the industry pushing case studies and build market-leading customer experiences.
Attend and gain unique insights on:

Collaborate or die.
Break internal silos in commercial and medical affairs, partner with healthcare’s key innovators and decision makers, and bring the brightest FMCG knowledge and leadership inside
You’re brand obsessed!
Create true customer partnerships and influence behaviours with an above-brand, education-led approach
Digital transformation needs a cultural revolution.
Demonstrate the value of digital initiatives to ensure adoption across affiliates and departments
Harness big data.
Personalise customer interactions with an internal infrastructure built to comprehend and connect insights
Achieve customer-centricity.
Ensure new channel innovations and digital investments remain purpose-led to meet customer needs
Real-life technological innovation.
Channel your investments and cut through unnecessary hyperbole with current applications of technology breakthroughs

4 Reasons to Attend:
Case Studies: Practical, tangible advice and actions from your peers which you can put into practise in your own company
Out of Industry Speakers: Hear from some of the biggest leader in marketing out of the pharma industry sharing their top tips
Team Benefits: Group rates are now available for 2+ attendees, to ensure all interested peers can take advantage of this learning opportunity
All Stakeholders in One Room: Working together to ensure we are engaging in solution focused exchanges across all departments
Book before 19th July to save €300

SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
2019-10-15 - 2019-10-16 | Holiday Inn Kesington Forum, London, UK, London, United Kingdom
SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK.

The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.
This is due to the arising interest for pharmaceutical companies, primarily for the underlying benefits, including the potential discovery of mechanisms for more common diseases, and the involvement of many smaller biotechnology start-up companies who are more focused on rare diseases.
The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerative orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.
BENEFITS OF ATTENDING

HEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs
DISCUSS the potential changes in assessing the development of medicines across Europe
EXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.

PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
Thursday 17th October 2019
A deep dive into strategies for accelerating patient access of orphan drugs
Workshop Leader: Workshop Leaders: Solange Corriol-Rohou, Senior Director Regulatory Affairs & Policy Europe, AstraZeneca
Cecile Ollivier, Chief Operating Officer, Aparito
WHO SHOULD ATTEND?
CEOs, CSOs, Vice Presidents, Directors, Heads, Principals working in:

Medical Affairs
Medical Advisory
Clinical Operations
Rare Disease Research
Patient Advocacy
Commercial Officer
Orphan Drug Therapeutics
Healthcare
Regulatory Affairs
Rare Disease Charity Officers

For more details and to register or this event, visit the website at http://www.orphandrugs.co.uk/PJWL
EARLY BIRD-RATES

BOOK BY 31ST MAY AND SAVE £400
BOOK BY 28TH JUNE AND SAVE £300
BOOK BY 30TH AUGUST AND SAVE £200

Flow Cytometry Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Flow Cytometry is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Liquid Biopsies Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Liquid Biopsies Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

TMB & Neoantigen Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The TMB & Neoantigen Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Adoptive Cell Transfer Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Novel Antibody Therapeutics Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Novel Antibody Therapeutics Congress one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Pharmaceutical Cleanroom Technology Europe Conference
2019-10-09 - 2019-10-10 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s Pharmaceutical Cleanroom Technology Europe Conference
Conference: Wednesday 9 and Thursday 10 October 2019
Workshop: Tuesday 8 October 2019
Location: Copthorne Tara Hotel, London, UK
www.cleanroomtechnology.co.uk/pjwl
Sponsored by: Contec and Dupont
CHAIRMAN: James Drinkwater, Chairman, Pharmaceutical & Healthcare Science Society
Addressing the Microbiological Aspects in Cleanroom Design and Engineering
SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, taking place on the 9th and 10th October 2019 in London, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.

This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals, biologicals, and cleanroom industry experts to explore hot topics within cleanroom design and engineering, best practices and regulation, environmental and contamination control, and pharmaceutical microbiology.
In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals, technological advancements in cleanrooms, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market.
Compliance with the standards for product approvals is crucial and as a result manufacturing companies in various industries are dependent on cleanroom technology.
BENEFITS OF ATTENDING

EXPLORE the characteristics and relevance of air flow to better advise cleanroom design, engineering and manage contamination
DISCUSS the most current approaches to minimised cost and improved energy efficiency without compromising product quality
EXAMINE the latest contamination control strategies from leaders in the pharmaceutical industry
GAIN insight into cleaning and disinfection protocols from a risk-management approach

PLUS AN INTERACTIVE HALF DAY PRE-CONFERENCE WORKSHOP
Tuesday 8th October 2019, Copthorne Tara Hotel, London, UK
Environmental Classification, Qualification and Monitoring of GMP Controlled areas referencing ISO 14644-1 and risk based GMP
Workshop Leader: James Drinkwater, Chairman, Pharmaceutical and Healthcare Science Society
WHO SHOULD ATTEND?
Senior Micro Manager, QC Manager, Quality Director, Clean Room Design Managers, Design, Qualify and Testing – Clean Room (across the board), Head of Clean Room Technologies, Head of Compounding Pharmacies, Head of Clinical Drug Products, Head of Clinical Medical Device
Global Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK, Europe and USA.
EARLY BIRD-RATES

BOOK BY 31ST MAY AND SAVE £400
BOOK BY 28TH JUNE AND SAVE £300
BOOK BY 30th AUGUST AND SAVE £200

4th European Prefilled Syringes Summit
2019-10-09 - 2019-10-10 | Berlin, Germany
After the three successful ACI’s European Prefilled Syringes Summit, we are pleased to inform you that the 4th edition will take place this month on the 9th & 10th October in Berlin, Germany.

The two day event will explore the advancements in regulatory guidelines including Article 117 and what this will mean for interactions with notified bodies. The conference will highlight technical advancements in product design and usage, looking at the move towards autoinjectors. Our expert speakers will compare the use of glass syringes with plastic syringes, focus on how to minimise the impact of extractables and leachables, and address CCI regulations. Through in-depth presentations and interactive panel discussions, the conference will shed light onto how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
Key Topics Include:

Medical Device Regulations overview and updates
Technical advancements in product design and usage
Suitability of primary packaging components
Extractables and leachables
Manufacturing and supply barriers
Improving adherence through device innovation and human factors
Creating value with connectivity
Developments in biologics
Shifting to a pay-per-outcome market

For more information & 15% subscribers discounted registration, contact Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net
Join us in Berlin to exchange your point of view with your peers and engage in excellent networking opportunities.

Blockchain for Health Supply Chain
2019-10-08 - 2019-10-09 | The Westin Boston Waterfront, 425 Summer St, Boston, MA, 02210, United States
Blockchain for Health Supply Chain: Real-World Application is the definitive event for all key stakeholders across the supply chain to forge a path for collaboration and adoption of this transformative technology. Consortium and tech-agnostic, this conference provides a neutral platform for cross-community sharing of PoCs and discussion about the common challenges facing all blockchain implementation projects.

In its 2nd year, this event will continue to tackle the deep and difficult challenges associated with blockchain implementation – providing essential guidance for active adopters as well as those preparing to embark on their blockchain journey. Our mission is to help you get beyond PoC – and to get blockchain out of the lab and into business.
Find out more – get free event brochure here: https://ter.li/p0t4xu
Contact
(+1) 617 455 4188
info@hansonwade.com

19th Pharmacovigilance 2019
2019-10-08 - 2019-10-10 | Double Tree Suites by Hilton Hotel – 400 Soldiers Field Road, Boston, MA 02134
19th Pharmacovigilance 2019
“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
08th – 10th October 2019, Hotel TBC, Cambridge, Boston, USA
19th Pharmacovigilance 2019 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. Hence, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting Pv development.
SPONSORS:

GOLD SPONSOR: Brookwood, AB Cube, AWINSA Life Sciences
BRONZE SPONSOR: 4C Pharma Solutions

KEY SPEAKERS:

DEREK ROY, Resident Agent in Charge, FDA
BRUNO MENDEZ, VP Global Quality Head Pharmacovigilance, Sanofi
MARIETTE BOERSTOEL-STREEFLAND, VP PharmacoVigilance & Drug Safety, Alexion Pharmaceuticals
TEGINDER SINGH, Senior Director Global Regulatory Affairs, Johnson & Johnson
COLLEEN WALSH, Senior Director, Pharmacovigilance & Regulatory Quality Management Operations, Alexion Pharmaceuticals
GERSON PELTZ, Senior Director – Oncology Safety Risk Lead, Pfizer
BRUCE DONZANTI, Senior Group Director, Regulatory Pharmacovigilance Policy, Genentech
WILLIAM WANG, Executive Director, Clinical Safety Statistics, Merck
MELVIN MUNSAKA, Senior Director, Head Safety Statistics, Abbvie
XIAO NI, Director, Scientific Computing and Consulting, Novartis
SHARON REID, Director, Risk Management Product Lead, Pfizer
HARISHA KADALI, Associate Medical Director, Takeda Pharmaceuticals
JAYLAXMI NALAWADE, Associate Director – Pharmacovigilance and REMS, Lupin
RICHARD WOLF, Executive Director, Pv Operations, CSL Behring
PHIL TREGUNNO, Group Manager – Vigilance, Intelligence and Research Group, MHRA (UK)
TOYIN ADEWOLE, Associate Director, Drug Safety – Clinical Research, Supernus Pharmaceuticals
SHEETAL KHEDAR, Senior Director, Regulatory Science, Sarah Cannon Development Innovations
DAVID HUTCHINSON, Founder, Brookwood International Academy
MELVA COVINGTON, Senior Principal, AGAPE Strategic Solutions
BEN LOCWIN, Senior Vice President, Quality, Lumicell

WHO SHOULD ATTEND:
CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:
Pharmacovigilance, Pharmacoepidemiology, Pharmacogenomics, Drug/Product Safety, Drug Development, Information and Clinical Data Management, Clinical Pharmacology, Clinical Safety, Periodical safety update Reports, Risk Management, Research & Development, Quality Assurance, Patient Safety, Signal Detection, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information technology, Sales and Marketing
CONFERENCE SPONSORSHIP:
E-mail – kavitha@virtueinsight.co.in or Tel: +44 2036120886
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available.
We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
CONFERENCE REGISTERATION:
In order to register contact us on Email: kavitha@virtueinsight.co.in Tel: +44 2036120886
Conference Only:

Introductory Offer (3 delegate places for the price of 2) A huge saving (Limited seats left)
Early Discount (25th June 2019 – 19th August 2019): (£1299 per delegate)
Standard Registration (20th August 2019 Onwards): (£1499 per delegate)

Conference + Workshop:

Introductory Offer (3 delegate places for the price of 2) A huge saving – (Limited seats left)
Early Discount (25th June 2019 – 19th August 201): (£1499 per delegate)
Standard Registration (20th August 2019 Onwards): (£1699 per delegate)

Workshop Oniy – £399
Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins. Expand your knowledge of the latest business models and strategies in the high-level conference.

The Marketing Disruption Summit USA
2019-10-02 - 2019-10-03 | Sheraton Philadelphia Society Hill Hotel
Harness data & tech to engage customers and dominate markets
As consumer attitudes shift to “one-click” pharma needs to shift with it.
Improving customer engagement strategies and processes are the key to improving reputations and delivering value. But how do we get there?
The answer, we can’t do it alone. The responsibility to deliver an excellent customer engagement strategy sits across several functions, at eyeforpharma Marketing Disruption Summit USA we’ll be going beyond the theoretical and bringing together all stakeholders to deliver a blueprint to revitalize customer relationships.
2019 Expert speakers include:

Anish Shindore, Head of Digital Acceleration, Sanofi
Martina Flammer, SVP, Customer Value, Boehringer Ingelheim
Judith Lyster, Digital/IT Leader Canada, Eli Lilly & Co.
Matt Smith, Global Lead, Strategy, Digital & Operations, Pfizer
Chad Dau, Head of Business and Market Analytics, Astellas
Ramon Vega, Director, Global Pharma Marketing IT, Merck

Over 200 attendees from across both front-end and back-end: Marketers, IT/technology, transformation agents, Data, Field Operations and more…will discuss how to unify efforts and develop strategy and process that performs in the field.
With the latest case studies from Sanofi, Pfizer and Ouchie, panels led by pharma leaders and out of industry expert sessions that will help you create the ultimate, effortless customer engagement strategy– this is the event to ensure your business is ready to dominate the market.

SMi’s 10th Annual Biosimilars Conference
2019-09-25 - 2019-09-26 | Copthorne Tara Hotel, London, UK, United Kingdom
Conference: Wednesday 25 and Thursday 26 September 2019
Workshop: Tuesday 24th September 2019
Chaired by Michel Mikhail, International Expert Regulatory Affairs, Global Expert Biosimilars
Discussing future regulatory, commercial and legal challenges of biosimilars
SMi Group are delighted to announce the 10th annual Biosimilars Conference taking place on 25th and 26th September 2019. This year’s event will be our first global event taking place in London, UK. The event’s focus is to highlight the current challenges in the biosimilars market and discuss current undergoing plans or developments to overcome these challenges.
The biosimilars market is forecasted to reach USD$23.6B by 2023 at a compound annual growth rate (CAGR) of 31.70%. Factors driving the increase of this market include growing demand for biosimilar drugs due to their cost-effectiveness, growing incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.
With the expiry dates of major patents fast approaching, the emerging gap in the market for biosimilars is now a major attraction for manufacturers. As the availability of biosimilars could potentially reduce direct spending by USD$54B by 2026, the question is what can current biosimilar producing companies do to join this market to benefit the patients, physicians and investors?
BENEFITS OF ATTENDING

HEAR about current strategies under development to overcome challenges with patents currently faced by many biosimilar developers
DISCUSS the possible changes in regulatory approval of biosimilars in the UK post Brexit, and how this will impact market entry
EXPLORE the latest methods in use to maintain the relationship between stakeholders, doctors and patients, with the influence of governing bodies
REVIEW FDA regulations for the approval of Biosimilars and the latest approvals

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS
Tuesday 24th September 2019, Copthorne Tara Hotel, Central London, UK
A: US-FDA Interchangeability Guideline
08.30 – 12.30
Workshop Leader: Michel Mikhail, International Expert Regulatory Affairs, Global Expert of Biosimilars
B: Global Development of Biosimilars – what can the US learn from Europe’s Strategies to promote biosimilar uptake
13:30 – 17:30
Workshop Leader: Rodeina Challand, General Manager, Challand Biosimilar Consulting
WHO SHOULD ATTEND?
Presidents, Vice Presidents, Managing Directors, Directors, Associate Directors, Chiefs, Heads, Principals, Managers and Analysts of:

Biosimilar Development
Product Development
Commercialization
Market Access
Medical Affairs
Intellectual Property
Bioloigcs
Biopharmaceuticals
Research and Development
Generics
Biobetters
Business Development
Strategic Marketing
Drug Development
Clinical Trials
Immunogenicity Studies

Global Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK, Europe and USA.
EARLY BIRD-RATES

BOOK BY 30TH APRIL AND SAVE £400
BOOK BY 31ST MAY AND SAVE £300
BOOK BY 28TH JUNE AND SAVE £200

Biobanking 2019
2019-09-25 - 2019-09-26 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
With the estimated revenues of the global biobanking industry reaching US$ 27.54 billion in 2020, backed by an explosive CAGR of 9.5% between now and 2026. This market growth is fuelled by the increasing drive towards precision and personalised medicine and thus, quality biosamples are now in soaring demand.

Come join us in September 2019 and; thoroughly understand the latest developments in the biobanking industry; network with the industry experts and key opinion leaders; gain insight into how the biobanking industry at the forefront at driving precision medicine and enhancing research and discover ‘Drone4Care’, how drone delivery of biosamples can be a reality.
The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. We will cover the most relevant hot topics including: the latest biorepository technological breakthroughs, the best practices in biobanking, shifts in the biosample regulation landscape, the international biobank societies with ESBB and ISBER, along with a whole host of successful biobanking business model structures to help reinvigorate your biobank.
Benefits of attending:

Discover ‘Drone4care’ from Laurent Dollé, the innovative and daring plan to use drones for the delivery of biomaterial. Additionally, he will be detailing the new promising technology of Tissue Microarray, a bioprocessing technology that can reduced the number of needed biosamples for research from 200 down to 1

Hear from UK Biobank on the continual impact of GDPR on the biobanking landscape

Learn about a diverse range of the most successful biobanking business models from real case studies

Gain insight from the global biobank collaboration societies of ESBB and ISBER, see how you can place your biobank on the international stage

View the full agenda online:
Early bird rates:

BOOK BY 30TH APRIL AND SAVE £400
BOOK BY 31ST MAY AND SAVE £300
BOOK BY THE 28TH JUNE AND SAVE £200

Plus, two interactive half day pre-conference workshops:
Workshop A: Enhance your biobank’s commercial prowess through the application of financial and economic tools along with how to improve your biosamples data quality
Workshop Leader: Laurent Dollé, Managing Director, BWB (Biothèque Wallonie Bruxelles)
8.30 – 12.30
Workshop B: The Organic Development of a Sustainable Academic Biobank
Workshop Leader: Mary-Beth Joshi, Director, Biobank & translational Research Core, Duke University Medical Centre
1.30 – 5.30
Follow us: @SMiPharm #smibiobanking
To learn more and to register online, visit www.biobanking-event.com/Pharmajwl

Asia Skin Microbiome 2.0 Congress
2019-09-24 - 2019-09-25 | Singapore – Hotel Fort Canning
This 2-day congress includes both scientific and commercial interests with topics ranging from host-microbe interaction, skin disease, emerging technologies, interventional and cosmetic advancements, and regulatory considerations. It features new and exciting case studies, presentations and expert-led panel discussions and an exhibition of solution providers showcasing products, and ample networking opportunities.
Specific focus areas include:

Skin health, wellbeing, and microbiome-associated skin disease
Skin immunology / Microbe-host interaction
Microbe-based therapies
Emerging technologies for skin microbiome research and innovation
Cosmetic vs Therapeutic regulatory considerations
Case studies / Academic-Commercial partnerships

10% OFF – code : sk/smca/10 expire on 26th Aug 2019. Contact : saffuan@global-engage.com for group booking

Microbiome Consumer Nutrition Congress
2019-09-24 - 2019-09-25 | Hotel Kabuki – 1625 Post St, San Francisco, California, United States, 94115
The Human Microbiome is a hot bed for scientific innovation and represents a rapidly growing area of focus for nutritional companies. Rising consumer consciousness around personal healthcare and diet, coupled with substantial improvements in R&D is fuelling a new wave of products that promote human gut health and wellbeing. The global probiotics market is expected to be worth $64 Bn by 2024, an increase of $20bn from 2017.
The Microbiome Consumer Nutrition Congress connects the dots between business, scientific innovation, regulation and product development in the converging fields of functional foods, pre/probiotics and the gut microbiome.
Top 10 reasons to attend:

Connect with and understand what leading nutrition, consumer health and CPG companies look for when forming strategic partnerships.
Understand the key branding and business features that VCs and Investors look for when investing in the next wave of gut health products, and how to build an effective investment deck to support your company’s next round of fundraising.
Discover the key ingredients leading health and wellness retailers seek for the next best-selling pre/probiotic products.
Discover the latest advancements in personalized microbiome diagnostics and how these can be translated into nutrition programs and products.
Understand the key business opportunities in the microbiome consumer nutrition space and how to capitalize on them.
Expand your understanding of the modern health and wellness consumer, the language they understand and what they’ll buy.
Apply the key take-aways from world leading microbiome consumer nutrition companies who have successfully branded and marketed their products and grown their businesses.
Discover the latest and most innovative scientific microbiome developments and how these can be utilized to develop the next generation of commercially successful consumer products.
Develop your understanding of regulatory considerations for microbiome-based products to improve the quality of your product’s claims and overcome regulation challenges.
Understand the timing and cost realities of bringing a gut probiotic to market and utilize this knowledge to efficiently release your next product.

The Skin Microbiome Congress Westcoast
2019-09-24 - 2019-09-25 | Hotel Kabuki, 1625 Post St, San Francisco, CA, 94115, United States
The microbiome is set to be one of 2019’s biggest skincare trends, therefore we are incredibly excited to bring The Skin Microbiome Congress back to San Francisco for the 6th event in our global series.

Last year, we connected 600+ industry leaders from pharma, beauty and personal care multinational brands with innovative independent skincare brands, bio-techs, researchers and academics who are advancing the skincare industry. This year, we continue to focus on developing a functional understanding of the skin microbiome, keeping up with the latest scientific research and competitive intelligence, as well as focusing on ‘the business of skin microbiome’ – commercializing the trend.
WHAT MAKES 2019 DIFFERENT?
New topics including skin microbiome based-products, skin conditions, personalization, skin-gut supplements, anti-ageing and commercializing ethically marketed and clinically proven products; as well as presenting the latest academic research – more researchers than ever will be showcasing the latest developments from top universities.
Also new for 2019, we are co-locating with our Microbiome Consumer Nutrition Congress – tailor your agenda and learn about the relationship of skin/gut microbiome and supplements.
Our 2018 event SOLD OUT, so make sure you don’t miss out! Download our agenda now.
To learn more about The Skin Microbiome Congress WestCoast, and to register online, visit https://go.kisacoresearch.com/l/678123/2019-05-30/5hp8
Contact:
Phone: +44 (0)203 897 6822
Email: mh@kisacoresearch.com

2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019
2019-09-19 | Kohinoor Continental Hotel, Mumbai, India, Mumbai, India
2nd Annual Pharma Packaging, Labelling, Serialisation,
Track and Trace 2019
“Securing your Supply Chain and Quality Management”
19th September 2019, Kohinoor Continental Hotel, Mumbai, India
2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems, this conference addresses serialisation; track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. Please contact me on KAVITHA at Email: kavitha@virtueinsight.co.in or Call: +91 9940791115.
CONFERENCE DELEGATE REGISTRATION:
In order to register contact us on E-mail – kavitha@virtueinsight.co.in Tel: +91 44 24762472 OR M: +91 9940791115
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.

Early Bird Discount Price (Valid until 06th August) – 1 Delegate – (INR 10,000 + GST (18%) per delegate)
Standard Price (Valid From 07th August) – 1 Delegate – (INR 15,000 + GST (18%) per delegate)
For Bulk Booking of More Than 5 Delegates – Please let us know your interests.

CONFERENCE SPONSORSHIP:
E-mail – kavitha@virtueinsight.co.in in Tel: +91 44 24762472 Or M: +91 9940791115
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available.
We also have some sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

Introducing the First list of confirmed Speakers

K. BANGARURAJAN, Joint Drugs Controller (INDIA), CDSCO (HQ)
RUBINA BOSE, Deputy Drugs Controller(India), CDSCO (WZ)
MAYUR PARMAR , Deputy Collector, Government Of Gujarat
SUDHIR MOHAN BANSAL, Vice President & India Head of Supply Chain Management, Pfizer
AMIT KALE, Associate Vice President – Packaging and Automation, Reliance
OMPRAKASH S. SADHWANI, Former Joint Commissioner and controlling Authority Food and Drug Administration (Maharashtra state)
CHANDRA SEKHAR, Vice President Quality, Reliance Life Sciences
UDAYKUMAR RAKIBE, Founder, PharmaMantra
VAIBHAV KULKARNI, Director – Regulatory Affairs, Abbott Nutrition
NARESH TONDARE, Senior Director – National Regulatory Affairs, Biocon
SUNIL ACHARYA , Packaging Development, S.C.P.L
RITESH GOHEL, Lead, Global Serialisation and Track & Trace, Sun Pharma
S.R.SALUNKHE, Former Assistant commissioner – FDA Maharashtra
PRABIR DAS, Head – Packaging Tech Services, OSD, Mylan Laboratories
SANJAY KUMAR, Head Of Legal, Emcure Pharmaceuticals
SANJAY DAVE, CCO, Anfarnd Consultancy Services
VISHWAS SOVANI, Founder Director, Pharmawisdom
GAURAJ SHAH, Counsel, Bombay High Court
VIRENDRA SINGH, Senior Manager, Reliance Life Sciences
JAGDISH VYAS, Manager, Abbott
RAJSHRI CHETAN PARDESHI, Manager – New Product & Commercial Packaging Development, and Sourcing Head for Regulated Market, Unosource Pharma (An Akums Enterprise)
DARSHAN VARTAK , Head Packaging Technical, Anchor by Panasonic

Plus many more
WHO SHOULD ATTEND:
CEO’s, CTO’s, CIO’s, Presidents, Vice Presidents, Directors Heads & Managers of:
Pharmaceutical manufacturers and distributors, Healthcare professionals, Pharmacists, Serialisation, Track and Trace – Solution providers, Brand – protection, enforcement, security, integrity and management companies, Drug regulatory agencies, customs and police, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection, Non-governmental organizations (NGOs) active in healthcare, Patients’ representatives, Healthcare research organizations, Pharmaceutical associations, Anti-counterfeiting organizations, Packaging, labeling and converting companies, Authentication technology suppliers, Anti-counterfeiting service suppliers – IP specialists, investigators, lawyers.
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

2nd Annual AI-ML Clinical Development Summit
2019-09-18 - 2019-09-19 | Aloft Boston Seaport District 401-403 D Street, Boston, MA, 02210, United States
Optimize When & How to Practically Apply AI & Machine Learning to Improve the Efficiency, Patient Recruitment, Design and Outcomes of Clinical Trials
Designed with leading AI and R&D experts from the likes of GSK, Pfizer, Takeda, Celgene, AbbVie and academic KOLs, & containing real world use cases of AI in action, this year’s AI-ML: Clinical Development Summit tackles both the critical scientific and technical challenges, as well as identifying opportunities, of implementing AI and machine learning (ML) to optimize your clinical development.
This is a critical time for drug developers to make more data-driven decisions that lead to improved efficacy, safety and approval outcomes. Only here you will learn when, strategically, it is the right time to invest and apply AI to transform your clinical trial success.
As clinical failure rates remain unsustainable and the vast amounts of patient data increases further, AI, data and clinical development and pharmacovigilance experts from across large pharma and biotech are gathering to discover the growing practical applications of AI and ML.
With 60+ thought-leaders converging at the AI-ML Clinical Development Summit, this will surely be an unrivalled opportunity for you to learn first-hand the growing practical applications of AI and ML.

Discover how to technically integrate and apply AI algorithms to enhance trial design, improve patient selection and retention and achieve more precise pharmacovigilance studies.
Grasp how AI will fundamentally change the paradigm of clinical trial execution and identify key areas where AI can positively impact your drug development decision making.
Harness AI and extract maximum value to achieve regulatory success and accelerate novel therapeutic products to market.

To learn more and to register online, visit: https://ai-clinicaldevelopment.com/
